<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33946763</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4705</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22094705</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are neurodegenerative disorders that exist on a disease spectrum due to pathological, clinical and genetic overlap. In up to 97% of ALS cases and ~50% of FTLD cases, the primary pathological protein observed in affected tissues is TDP-43, which is hyperphosphorylated, ubiquitinated and cleaved. The TDP-43 is observed in aggregates that are abnormally located in the cytoplasm. The pathogenicity of TDP-43 cytoplasmic aggregates may be linked with both a loss of nuclear function and a gain of toxic functions. The cellular processes involved in ALS and FTLD disease pathogenesis include changes to RNA splicing, abnormal stress granules, mitochondrial dysfunction, impairments to axonal transport and autophagy, abnormal neuromuscular junctions, endoplasmic reticulum stress and the subsequent induction of the unfolded protein response. Here, we review and discuss the evidence for alterations to these processes that have been reported in cellular and animal models of TDP-43 proteinopathy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Alistair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Molecular Science, University of Western Australia, Nedlands 6009, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurfinkel</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Nedlands 6009, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polain</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0020-3687</Identifier><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamont</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Nedlands 6009, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyn Rea</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2181-9491</Identifier><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Health Research Building, Discovery Way, Murdoch 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hub for Immersive Visualisation and eResearch, Curtin University, Bentley 6102, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands 6009, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000627100">Tardbp protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">TARDBP/TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">proteinopathy</Keyword><Keyword MajorTopicYN="N">proteostasis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33946763</ArticleId><ArticleId IdType="pmc">PMC8125728</ArticleId><ArticleId IdType="doi">10.3390/ijms22094705</ArticleId><ArticleId IdType="pii">ijms22094705</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Manzoni C., Hardy J. Genetics and molecular mechanisms of frontotemporal lobar degeneration: An update and future avenues. Neurobiol. Aging. 2019;78:98&#x2013;110. doi: 10.1016/j.neurobiolaging.2019.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.02.006</ArticleId><ArticleId IdType="pubmed">30925302</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Halliday G.M., Kril J.J., Ittner L.M., Gotz J., Kiernan M.C., Hodges J.R. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., Vasta R., Brunetti M., Barberis M., Corrado L., D&#x2019;Alfonso S., Bersano E., et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984&#x2013;e994. doi: 10.1212/WNL.0000000000008063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008063</ArticleId><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: An update. Mol. Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaus A., Sareen D. ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad. Front. Cell Neurosci. 2015;9:448. doi: 10.3389/fncel.2015.00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00448</ArticleId><ArticleId IdType="pmc">PMC4652136</ArticleId><ArticleId IdType="pubmed">26635528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Pandey U.B. Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand. Front. Mol. Neurosci. 2017;10:263. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger B.N., Dickson D.W. Pathology of Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2017:9. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday G., Bigio E.H., Cairns N.J., Neumann M., Mackenzie I.R., Mann D.M. Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects. Acta Neuropathol. 2012;124:373&#x2013;382. doi: 10.1007/s00401-012-1030-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1030-4</ArticleId><ArticleId IdType="pmc">PMC3445027</ArticleId><ArticleId IdType="pubmed">22878865</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Purice M.D., Taylor J.P. Linking hnRNP Function to ALS and FTD Pathology. Front. Neurosci. 2018;12:326. doi: 10.3389/fnins.2018.00326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00326</ArticleId><ArticleId IdType="pmc">PMC5962818</ArticleId><ArticleId IdType="pubmed">29867335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018 doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., Legallic S., Salachas F., Hannequin D., Decousus M., et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 2009;65:470&#x2013;473. doi: 10.1002/ana.21612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21612</ArticleId><ArticleId IdType="pubmed">19350673</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni B., Bonvicini C., Alberici A., Buratti E., Agosti C., Archetti S., Papetti A., Stuani C., Di Luca M., Gennarelli M., et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 2009;30:E974&#x2013;E983. doi: 10.1002/humu.21100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21100</ArticleId><ArticleId IdType="pubmed">19655382</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Nonoka T., Kametani F., Yamashita M., Hosokawa M., Niizato K., Tsuchiya K., Kobayashi Z., Ikeda K., et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology. 2010;30:170&#x2013;181. doi: 10.1111/j.1440-1789.2009.01089.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01089.x</ArticleId><ArticleId IdType="pubmed">20102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumann M. Molecular neuropathology of frontotemporal dementia: Insights into disease mechanisms from postmortem studies. J. Neurochem. 2016;138(Suppl. S1):54&#x2013;70. doi: 10.1111/jnc.13588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13588</ArticleId><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Audet J.N., Phaneuf D., Kriz J., Julien J.P. Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis. J. Neurosci. 2012;32:18186&#x2013;18195. doi: 10.1523/JNEUROSCI.2267-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2267-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621743</ArticleId><ArticleId IdType="pubmed">23238732</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S.W., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Yan T., Perry G., Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell Neurosci. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M., Buratti E., Morselli E., Criollo A. Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72. Front. Mol. Neurosci. 2017;10:170. doi: 10.3389/fnmol.2017.00170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00170</ArticleId><ArticleId IdType="pmc">PMC5447761</ArticleId><ArticleId IdType="pubmed">28611593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iguchi Y., Katsuno M., Sobue G. Alterations in the blood-spinal cord barrier in TDP-43 conditional knockout mice. Neurosci. Lett. 2015;598:1&#x2013;5. doi: 10.1016/j.neulet.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.05.005</ArticleId><ArticleId IdType="pubmed">25957558</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran P., Shaw C., Guthrie S. TDP-43 causes neurotoxicity and cytoskeletal dysfunction in primary cortical neurons. PLoS ONE. 2018;13:e0196528. doi: 10.1371/journal.pone.0196528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0196528</ArticleId><ArticleId IdType="pmc">PMC5963761</ArticleId><ArticleId IdType="pubmed">29787572</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.H., Yu T.H., Ryu H.H., Jun M.H., Ban B.K., Jang D.J., Lee J.A. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp. Cell Res. 2013;319:1998&#x2013;2005. doi: 10.1016/j.yexcr.2013.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2013.05.025</ArticleId><ArticleId IdType="pubmed">23742895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M., Nonaka T., Hirai S., Miwa A., Okado H., Arai T., Hosokawa M., Akiyama H., Hasegawa M. Distinct pathways leading to TDP-43-induced cellular dysfunctions. Hum. Mol. Genet. 2014;23:4345&#x2013;4356. doi: 10.1093/hmg/ddu152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu152</ArticleId><ArticleId IdType="pubmed">24698978</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Kaneko K., Yamanaka K. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J. Biol. Chem. 2013;288:3641&#x2013;3654. doi: 10.1074/jbc.M112.433615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.433615</ArticleId><ArticleId IdType="pmc">PMC3561582</ArticleId><ArticleId IdType="pubmed">23235148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Bassell G.J., Rossoll W. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 2012;21:3703&#x2013;3718. doi: 10.1093/hmg/dds205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargsted L., Medinas D.B., Mart&#xed;nez Traub F., Rozas P., Mu&#xf1;oz N., Nassif M., Jerez C., Catenaccio A., Court F.A., Hetz C., et al. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43(A315T) ALS/FTD mouse model. Sci. Rep. 2017;7:14266. doi: 10.1038/s41598-017-14399-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14399-5</ArticleId><ArticleId IdType="pmc">PMC5660202</ArticleId><ArticleId IdType="pubmed">29079747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Handley E., Brizuela M., Dawkins E., Lewis K.E.A., Clark R.M., Dickson T.C., Blizzard C.A. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function. Dis. Model. Mech. 2019:12. doi: 10.1242/dmm.038109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.038109</ArticleId><ArticleId IdType="pmc">PMC6550035</ArticleId><ArticleId IdType="pubmed">31036551</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti L., Gilley J., Coleman M.P. Wallerian degeneration: An emerging axon death pathway linking injury and disease. Nat. Rev. Neurosci. 2014;15:394&#x2013;409. doi: 10.1038/nrn3680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3680</ArticleId><ArticleId IdType="pubmed">24840802</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Lin Z., Kim E., Henstridge C.M., Pena Altamira E., Hunt C.K., Burchill E., Callaghan I., Loreto A., Brown-Wright H., et al. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathol. Commun. 2019;7:166. doi: 10.1186/s40478-019-0800-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0800-9</ArticleId><ArticleId IdType="pmc">PMC6819591</ArticleId><ArticleId IdType="pubmed">31661035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand K.K., Lee K.M., Lee J.D., Qiu H., Willis E.F., Lavidis N.A., Hilliard M.A., Noakes P.G. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43(Q331K) transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2018;32:2676&#x2013;2689. doi: 10.1096/fj.201700835R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700835R</ArticleId><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.L., Wu L.S., Lee M., Chang C.W., Cheng W.C., Fang Y.S., Chen Y.R., Cheng P.L., Shen C.J. A robust TDP-43 knock-in mouse model of ALS. Acta Neuropathol. Commun. 2020;8:3. doi: 10.1186/s40478-020-0881-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0881-5</ArticleId><ArticleId IdType="pmc">PMC6975031</ArticleId><ArticleId IdType="pubmed">31964415</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Vance C., Nishimura A.L., Lee Y.B., Chen H.J., Urwin H., Sardone V., Mitchell J.C., Rogelj B., Rubinsztein D.C., et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.C., Bose J.K., Majumder P., Lee K.H., Huang J.T., Huang J.K., Shen C.K. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43. J. Cell Sci. 2014;127:3024&#x2013;3038. doi: 10.1242/jcs.136150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.136150</ArticleId><ArticleId IdType="pubmed">24860144</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Lin F., Robertson C.S., Wang K.K. Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury. J. Cereb. Blood Flow Metab. 2014;34:1444&#x2013;1452. doi: 10.1038/jcbfm.2014.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.105</ArticleId><ArticleId IdType="pmc">PMC4158661</ArticleId><ArticleId IdType="pubmed">24917042</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Capell A., Carlson A.M., Shankaran S.S., Rodde R., Neumann M., Kremmer E., Matsuwaki T., Yamanouchi K., Nishihara M., et al. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J. Neurochem. 2009;110:1082&#x2013;1094. doi: 10.1111/j.1471-4159.2009.06211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06211.x</ArticleId><ArticleId IdType="pubmed">19522733</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. J. Biol. Chem. 2009;284:8516&#x2013;8524. doi: 10.1074/jbc.M809462200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809462200</ArticleId><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Kametani F., Arai T., Akiyama H., Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009;18:3353&#x2013;3364. doi: 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 2007;27:10530&#x2013;10534. doi: 10.1523/JNEUROSCI.3421-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3421-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673167</ArticleId><ArticleId IdType="pubmed">17898224</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S., et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582:2899&#x2013;2904. doi: 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Tripathy K., Restrepo C.R., Ge G., Xu Y., Kwong L.K., Trojanowski J.Q., Lee V.M. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice. Hum. Mol. Genet. 2015;24:7241&#x2013;7254. doi: 10.1093/hmg/ddv424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv424</ArticleId><ArticleId IdType="pmc">PMC5007600</ArticleId><ArticleId IdType="pubmed">26476406</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Nukina N. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site. Biochim. Biophys. Acta. 2011;1812:1577&#x2013;1583. doi: 10.1016/j.bbadis.2011.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2011.09.005</ArticleId><ArticleId IdType="pubmed">21946215</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady O.A., Meng P., Zheng Y., Mao Y., Hu F. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J. Neurochem. 2011;116:248&#x2013;259. doi: 10.1111/j.1471-4159.2010.07098.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07098.x</ArticleId><ArticleId IdType="pubmed">21062285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Lim L., Wang L., Song J. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity. Biochem. Biophys. Res. Commun. 2017;485:826&#x2013;831. doi: 10.1016/j.bbrc.2017.02.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.02.139</ArticleId><ArticleId IdType="pubmed">28257838</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Chen Y., Zhou X., Kar A., Ray P., Chen X., Rao E.J., Yang M., Ye H., Zhu L., et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011;18:822&#x2013;830. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoseki A., Shiga A., Tan C.F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 2008;63:538&#x2013;542. doi: 10.1002/ana.21392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21392</ArticleId><ArticleId IdType="pubmed">18438952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L., Ratti A., Gellera C., Buratti E., Castellotti B., Carlomagno Y., Ticozzi N., Mazzini L., Testa L., Taroni F., et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum. Mutat. 2009;30:688&#x2013;694. doi: 10.1002/humu.20950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20950</ArticleId><ArticleId IdType="pubmed">19224587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Alexeeva O.M., Yamada S., Pribadi A., Zhang Y., Mo B., Williams K.R., Zarnescu D.C., Rossoll W. PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum. Mol. Genet. 2015;24:5154&#x2013;5173. doi: 10.1093/hmg/ddv238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv238</ArticleId><ArticleId IdType="pmc">PMC4550816</ArticleId><ArticleId IdType="pubmed">26130692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Nakayama Y., Shibasaki A., Taki A., Yuno S., Takeda K., Yahara M., Tanabe N., Kinjo M. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity. Sci. Rep. 2016;6:19230. doi: 10.1038/srep19230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19230</ArticleId><ArticleId IdType="pmc">PMC4725827</ArticleId><ArticleId IdType="pubmed">26757674</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Tan W., Whittle C., Qiu L., Cao L., Akbarian S., Xu Z. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS ONE. 2010;5:e15878. doi: 10.1371/journal.pone.0015878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015878</ArticleId><ArticleId IdType="pmc">PMC3013128</ArticleId><ArticleId IdType="pubmed">21209826</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Lee E.B., Chen-Plotkin A., Swanson E., Unger T., Malunda J., Xu Y., Winton M.J., Trojanowski J.Q., et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Investig. 2011;121:726&#x2013;738. doi: 10.1172/JCI44867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44867</ArticleId><ArticleId IdType="pmc">PMC3026736</ArticleId><ArticleId IdType="pubmed">21206091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaguri H., Chew J., Xu Y.F., Gendron T.F., Garrett A., Lee C.W., Jansen-West K., Bauer P.O., Perkerson E.A., Tong J., et al. The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo. Brain Res. 2016;1647:57&#x2013;64. doi: 10.1016/j.brainres.2016.04.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.069</ArticleId><ArticleId IdType="pmc">PMC5003772</ArticleId><ArticleId IdType="pubmed">27155453</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Spiller K.J., Ge G., Zheng A., Xu Y., Zhou M., Tripathy K., Kwong L.K., Trojanowski J.Q., Lee V.M. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Restrepo C.R., Yuan C.X., Trojanowski J.Q., Lee V.M. An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 2015;6:5845. doi: 10.1038/ncomms6845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Obi T., Shishido T., Akatsu H., Murayama S., Saito Y., Yoshida M., Hasegawa M. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 2016;6:23281. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna S., Esposito S., Masala A., Sini P., Nieddu G., Galioto M., Fais M., Iaccarino C., Cestra G., Crosio C. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death Dis. 2020;11:369. doi: 10.1038/s41419-020-2580-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2580-3</ArticleId><ArticleId IdType="pmc">PMC7224392</ArticleId><ArticleId IdType="pubmed">32409664</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Lu S., Gasior K., Singh D., Vazquez-Sanchez S., Tapia O., Toprani D., Beccari M.S., Yates J.R., III, Da Cruz S., et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science. 2021;371:6529. doi: 10.1126/science.abb4309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4309</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Eckert M., von Zweydorf F., Gloeckner C.J., Kahle P.J. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2018;293:16083&#x2013;16099. doi: 10.1074/jbc.RA118.003440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003440</ArticleId><ArticleId IdType="pmc">PMC6187624</ArticleId><ArticleId IdType="pubmed">30120199</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau A., Veyrat-Durebex C., Blasco H., Praline J., Corcia P., Andres C.R., Vourc&#x2019;h P. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int. J. Neurosci. 2013;123:366&#x2013;374. doi: 10.3109/00207454.2012.761984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2012.761984</ArticleId><ArticleId IdType="pubmed">23289752</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E., Rosenblum L., Bogush A.I., Trotti D. Sumoylation of critical proteins in amyotrophic lateral sclerosis: Emerging pathways of pathogenesis. Neuromolecular Med. 2013;15:760&#x2013;770. doi: 10.1007/s12017-013-8262-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-013-8262-x</ArticleId><ArticleId IdType="pmc">PMC3832993</ArticleId><ArticleId IdType="pubmed">24062161</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfried N.T., Gozal Y.M., Dammer E.B., Xia Q., Duong D.M., Cheng D., Lah J.J., Levey A.I., Peng J. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol. Cell Proteom. 2010;9:705&#x2013;718. doi: 10.1074/mcp.M800390-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M800390-MCP200</ArticleId><ArticleId IdType="pmc">PMC2860236</ArticleId><ArticleId IdType="pubmed">20047951</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurel C., Chami A.A., Th&#xe9;pault R.A., Marouillat S., Blasco H., Corcia P., Andres C.R., Vourc&#x2019;h P. A role for SUMOylation in the Formation and Cellular Localization of TDP-43 Aggregates in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2020;57:1361&#x2013;1373. doi: 10.1007/s12035-019-01810-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01810-7</ArticleId><ArticleId IdType="pubmed">31728929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Topp S.D., Hui H.S., Zacco E., Katarya M., McLoughlin C., King A., Smith B.N., Troakes C., Pastore A., et al. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain. 2019;142:3753&#x2013;3770. doi: 10.1093/brain/awz313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz313</ArticleId><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., Constable R., So E., Vance C., Scotter E., Glover L., Hortobagyi T., Arnold E.S., Ling S.C., McAlonis M., et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 2015;3:36. doi: 10.1186/s40478-015-0212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0212-4</ArticleId><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458.e447. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnard-Gu&#xe9;rin C. Cytoplasmic localization of amyotrophic lateral sclerosis-related TDP-43 proteins modulates stress granule formation. Eur. J. Neurosci. 2020;52:3995&#x2013;4008. doi: 10.1111/ejn.14762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14762</ArticleId><ArticleId IdType="pubmed">32343854</ArticleId></ArticleIdList></Reference><Reference><Citation>French R.L., Grese Z.R., Aligireddy H., Dhavale D.D., Reeb A.N., Kedia N., Kotzbauer P.T., Bieschke J., Ayala Y.M. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation. J. Biol. Chem. 2019;294:6696&#x2013;6709. doi: 10.1074/jbc.RA118.005889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005889</ArticleId><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa K., Handa H., Kawakami K. Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in the spinal motor neurons. Nat. Commun. 2020;11:1004. doi: 10.1038/s41467-020-14815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14815-x</ArticleId><ArticleId IdType="pmc">PMC7035286</ArticleId><ArticleId IdType="pubmed">32081878</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y.S., Tsai K.J., Chang Y.J., Kao P., Woods R., Kuo P.H., Wu C.C., Liao J.Y., Chou S.C., Lin V., et al. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat. Commun. 2014;5:4824. doi: 10.1038/ncomms5824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5824</ArticleId><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F., Salvatori I., Iacovelli F., Mirra A., Rossi S., Cozzolino M., Falconi M., Valle C., Carr&#xec; M.T. Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells. Neurobiol. Dis. 2016;94:63&#x2013;72. doi: 10.1016/j.nbd.2016.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.006</ArticleId><ArticleId IdType="pubmed">27317832</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Xue W., Hong J.Y., Zhang J.T., Li M.J., Yu S.N., He J.H., Hu H.Y. The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep. 2017;7:6196. doi: 10.1038/s41598-017-06263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06263-3</ArticleId><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh C.W., Lee I.C., Sundaram J.R., George S.E., Yusoff P., Brush M.H., Sze N.S.K., Shenolikar S. Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration. J. Biol. Chem. 2018;293:163&#x2013;176. doi: 10.1074/jbc.M117.814111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.814111</ArticleId><ArticleId IdType="pmc">PMC5766914</ArticleId><ArticleId IdType="pubmed">29109149</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Suzuki G., Tanaka Y., Kametani F., Hirai S., Okado H., Miyashita T., Saitoe M., Akiyama H., Masai H., et al. Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1&#x3b4; Triggers Mislocalization and Accumulation of TDP-43. J. Biol. Chem. 2016;291:5473&#x2013;5483. doi: 10.1074/jbc.M115.695379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.695379</ArticleId><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 2010;30:639&#x2013;649. doi: 10.1523/JNEUROSCI.4988-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Caulfield T., Xu Y.F., Gendron T.F., Hubbard J., Stetler C., Sasaguri H., Whitelaw E.C., Cai S., Lee W.C., et al. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet. 2013;22:3112&#x2013;3122. doi: 10.1093/hmg/ddt166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitini C., Conti S., Perni M., Guidi F., Cascella R., De Poli A., Penco A., Relini A., Cecchi C., Chiti F. TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells. PLoS ONE. 2014;9:e86720. doi: 10.1371/journal.pone.0086720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086720</ArticleId><ArticleId IdType="pmc">PMC3907574</ArticleId><ArticleId IdType="pubmed">24497973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon A., Yang B., Knight J., Farnham I.M., Zhang Y., Wuertzer C.A., D&#x2019;Alton S., Lin W.L., Castanedes-Casey M., Rousseau L., et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathol. 2012;123:807&#x2013;823. doi: 10.1007/s00401-012-0979-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0979-3</ArticleId><ArticleId IdType="pmc">PMC3359456</ArticleId><ArticleId IdType="pubmed">22539017</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai A., Kato T., Koyama A., Koike Y., Kasahara S., Konno T., Ishihara T., Onodera O. Robustness and Vulnerability of the Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for ALS Pathology Based on in Silico Data. Front. Neurosci. 2018;12:28. doi: 10.3389/fnins.2018.00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00028</ArticleId><ArticleId IdType="pmc">PMC5799296</ArticleId><ArticleId IdType="pubmed">29449800</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Barmada S.J. TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res. 2018;1693:67&#x2013;74. doi: 10.1016/j.brainres.2018.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.015</ArticleId><ArticleId IdType="pmc">PMC5997512</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., De Conti L., Avenda&#xf1;o-V&#xe1;zquez S.E., Dhir A., Romano M., D&#x2019;Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Hara-Miyauchi C., Ohta H., Sakimura K., Okano H., Okano H.J. Analysis of RNA metabolism in peripheral WBCs of TDP-43 KI mice identifies novel biomarkers of ALS. Neurosci. Res. 2016;106:12&#x2013;22. doi: 10.1016/j.neures.2015.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2015.11.009</ArticleId><ArticleId IdType="pubmed">26672899</ArticleId></ArticleIdList></Reference><Reference><Citation>Glock C., Heum&#xfc;ller M., Schuman E.M. mRNA transport &amp; local translation in neurons. Curr. Opin. Neurobiol. 2017;45:169&#x2013;177. doi: 10.1016/j.conb.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.05.005</ArticleId><ArticleId IdType="pubmed">28633045</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilaz L.J., Silver D.L. Moving messages in the developing brain-emerging roles for mRNA transport and local translation in neural stem cells. FEBS Lett. 2017;591:1526&#x2013;1539. doi: 10.1002/1873-3468.12626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12626</ArticleId><ArticleId IdType="pmc">PMC5497576</ArticleId><ArticleId IdType="pubmed">28304078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal P.P., Nirschl J.J., Klinman E., Holzbaur E.L. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc. Natl. Acad. Sci. USA. 2017;114:E2466&#x2013;e2475. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J.F., Majumder P., Chatterjee B., Huang S.L., Shen C.J. TDP-43 Regulates Coupled Dendritic mRNA Transport-Translation Processes in Co-operation with FMRP and Staufen1. Cell Rep. 2019;29:3118&#x2013;3133.e3116. doi: 10.1016/j.celrep.2019.10.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.061</ArticleId><ArticleId IdType="pubmed">31801077</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Li X., Malik A.M., Martinez J., Beg A.A., Barmada S.J. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration. Cell Rep. 2019;27:1133&#x2013;1150.e1138. doi: 10.1016/j.celrep.2019.03.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.093</ArticleId><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R., Matsukawa K., Nagata Y., Kunugi H., Tsuji S., Chihara T., Kuranaga E., Miura M., Wakabayashi T., Hashimoto T., et al. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum. Mol. Genet. 2013;22:4474&#x2013;4484. doi: 10.1093/hmg/ddt296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt296</ArticleId><ArticleId IdType="pubmed">23804749</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F.C., Kaur K., M&#xfc;ller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE. 2010;5:e12247. doi: 10.1371/journal.pone.0012247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A., Sun M., Ling J.P., Braunstein K.E., Pang B., Wen X., Cheng X., Chen L., Wong P.C. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;138:813&#x2013;826. doi: 10.1007/s00401-019-02042-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02042-8</ArticleId><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Chitta R.K., High A.A., Taylor J.P. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y., Dewey C.M., Roth F.P., Herz J., Peng J., et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 2011;286:1204&#x2013;1215. doi: 10.1074/jbc.M110.190884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-linked TDP-43 Mutations Produce Aberrant RNA Splicing and Adult-Onset Motor Neuron Disease Without Aggregation or Loss of Nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013;100:E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L., Felemban R., Scott D.D., Sayegh M.R., Miranda V.G., Perez-Miller S., Khanna R., Gokhale V., Zarnescu D.C., Khanna M. Small Molecule Targeting TDP-43&#x2032;s RNA Recognition Motifs Reduces Locomotor Defects in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS) ACS Chem. Biol. 2019;14:2006&#x2013;2013. doi: 10.1021/acschembio.9b00481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.9b00481</ArticleId><ArticleId IdType="pmc">PMC6911355</ArticleId><ArticleId IdType="pubmed">31241884</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Sivakumar P., Humphrey J., Lo K., Ricketts T., Oliveira H., Brito-Armas J.M., Kalmar B., Ule A., Yu Y., et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018;37 doi: 10.15252/embj.201798684.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Yang H., Yan S., Wang C.E., Liu X., Zhao B., Ouyang Z., Yin P., Liu Z., Zhao Y., et al. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain. Mol. Neurodegener. 2015;10:42. doi: 10.1186/s13024-015-0036-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0036-5</ArticleId><ArticleId IdType="pmc">PMC4557629</ArticleId><ArticleId IdType="pubmed">26334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Oiwa K., Murata Y., Komine O., Sobue A., Endo F., Takahashi E., Yamanaka K. ALS-linked TDP-43(M337V) knock-in mice exhibit splicing deregulation without neurodegeneration. Mol. Brain. 2020;13:8. doi: 10.1186/s13041-020-0550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0550-4</ArticleId><ArticleId IdType="pmc">PMC6971932</ArticleId><ArticleId IdType="pubmed">31959210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.C., Hazelett D.J., Stewart J.A., Morton D.B. Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. Brain Res. 2014;1584:39&#x2013;51. doi: 10.1016/j.brainres.2013.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.11.019</ArticleId><ArticleId IdType="pmc">PMC4031311</ArticleId><ArticleId IdType="pubmed">24275199</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima M., Hosoda N., Chifu K., Hoshino S.I. TDP-43 accelerates deadenylation of target mRNAs by recruiting Caf1 deadenylase. FEBS Lett. 2019;593:277&#x2013;287. doi: 10.1002/1873-3468.13310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13310</ArticleId><ArticleId IdType="pubmed">30520513</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M., Saal-Bauernschubert L., L&#xfc;ningschr&#xf6;r P., Moradi M., Dombert B., Surrey V., Appenzeller S., Deng C., Jablonka S., Sendtner M. Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol. Commun. 2020;8:116. doi: 10.1186/s40478-020-00987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00987-6</ArticleId><ArticleId IdType="pmc">PMC7379803</ArticleId><ArticleId IdType="pubmed">32709255</ArticleId></ArticleIdList></Reference><Reference><Citation>Keihani S., Kluever V., Mandad S., Bansal V., Rahman R., Fritsch E., Gomes L.C., G&#xe4;rtner A., K&#xfc;gler S., Urlaub H., et al. The long noncoding RNA neuroLNC regulates presynaptic activity by interacting with the neurodegeneration-associated protein TDP-43. Sci. Adv. 2019;5:eaay2670. doi: 10.1126/sciadv.aay2670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aay2670</ArticleId><ArticleId IdType="pmc">PMC6920028</ArticleId><ArticleId IdType="pubmed">31897430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D., Dafinca R., Scaber J., Alegre-Abarrategui J., Farrimond L., Scott C., Biggs D., Kent L., Oliver P.L., Davies B., et al. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiol. Dis. 2019;121:148&#x2013;162. doi: 10.1016/j.nbd.2018.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.09.024</ArticleId><ArticleId IdType="pubmed">30290270</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques R.F., Engler J.B., K&#xfc;chler K., Jones R.A., Lingner T., Salinas G., Gillingwater T.H., Friese M.A., Duncan K.E. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models. Hum. Mol. Genet. 2020;29:2647&#x2013;2661. doi: 10.1093/hmg/ddaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa140</ArticleId><ArticleId IdType="pmc">PMC7530531</ArticleId><ArticleId IdType="pubmed">32686835</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelagandan N., Gonnella G., Dang S., Janiesch P.C., Miller K.K., K&#xfc;chler K., Marques R.F., Indenbirken D., Alawi M., Grundhoff A., et al. TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. Nucleic Acids Res. 2019;47:341&#x2013;361. doi: 10.1093/nar/gky972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky972</ArticleId><ArticleId IdType="pmc">PMC6326785</ArticleId><ArticleId IdType="pubmed">30357366</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 2012;287:15635&#x2013;15647. doi: 10.1074/jbc.M111.333450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Wu F., Xu W., Shi J., Hu W., Jin N., Qian W., Wang X., Iqbal K., Gong C.X., et al. TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res. 2017;45:6177&#x2013;6193. doi: 10.1093/nar/gkx175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx175</ArticleId><ArticleId IdType="pmc">PMC5449590</ArticleId><ArticleId IdType="pubmed">28335005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose J.K., Huang C.C., Shen C.K. Regulation of autophagy by neuropathological protein TDP-43. J. Biol. Chem. 2011;286:44441&#x2013;44448. doi: 10.1074/jbc.M111.237115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.237115</ArticleId><ArticleId IdType="pmc">PMC3247982</ArticleId><ArticleId IdType="pubmed">22052911</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Wang H., Hao Z., Fu C., Hu Q., Gao F., Ren H., Chen D., Han J., Ying Z., et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J. 2016;35:121&#x2013;142. doi: 10.15252/embj.201591998.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201591998</ArticleId><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., K&#xf6;nig J., Hortob&#xe1;gyi T., Nishimura A.L., Zupunski V., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro A., Kimura N., Noma T., Shimo-Kon R., Ishihama A., Kon T. Molecular dissection of ALS-linked TDP-43-involvement of the Gly-rich domain in interaction with G-quadruplex mRNA. FEBS Lett. 2020;594:2254&#x2013;2265. doi: 10.1002/1873-3468.13800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13800</ArticleId><ArticleId IdType="pubmed">32337711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Anderson P. Stress granules: Sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 2002;30:963&#x2013;969. doi: 10.1042/bst0300963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0300963</ArticleId><ArticleId IdType="pubmed">12440955</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., Dries D.R., Mayer P., 3rd, Good S.K., Johnson B.A., Herz J., Yu G. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell Biol. 2011;31:1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Soo K.Y., Sundaramoorthy V., Parakh S., Ma Y., Farg M.A., Wallace R.H., Crouch P.J., Turner B.J., Horne M.K., et al. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS ONE. 2013;8:e81170. doi: 10.1371/journal.pone.0081170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081170</ArticleId><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G.A., Vande Velde C. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 2011;20:1400&#x2013;1410. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; S., Coni P., Floris A., Littera R., Carcassi C., Sogos V., Brancia C. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: Evidence for loss of TDP-43 nuclear function. Hum. Mol. Genet. 2016;25:4473&#x2013;4483. doi: 10.1093/hmg/ddw276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw276</ArticleId><ArticleId IdType="pubmed">28172957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Lin A.Y., Ebata A., Boon J.Y., Reid W., Xu Y.F., Kobrin K., Murphy G.J., Petrucelli L., Wolozin B. ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J. Neurosci. 2014;34:4167&#x2013;4174. doi: 10.1523/JNEUROSCI.2350-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2350-13.2014</ArticleId><ArticleId IdType="pmc">PMC3960463</ArticleId><ArticleId IdType="pubmed">24647938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M.Y., Markmiller S., Vu A.Q., Javaherian A., Dowdle W.E., Jolivet P., Bushway P.J., Castello N.A., Baral A., Chan M.Y., et al. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD. Neuron. 2019;103:802&#x2013;819.e811. doi: 10.1016/j.neuron.2019.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.048</ArticleId><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., Chen C., Melamed Z., Guo L., Shorter J., Da Cruz S., Cleveland D.W. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102:339&#x2013;357.e337. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Dignon G.L., Zerze G.H., Schmidt H.B., D&#x2019;Ordine A.M., Kim Y.C., Rohatgi R., Ayala Y.M., Mittal J., Fawzi N.L. TDP-43 &#x3b1;-helical structure tunes liquid-liquid phase separation and function. Proc. Natl. Acad. Sci. USA. 2020;117:5883&#x2013;5894. doi: 10.1073/pnas.1912055117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1912055117</ArticleId><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.R., Chiang W.C., Chou P.C., Wang W.J., Huang J.R. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues. J. Biol. Chem. 2018;293:6090&#x2013;6098. doi: 10.1074/jbc.AC117.001037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.AC117.001037</ArticleId><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J., et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102:321&#x2013;338.e328. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi K.J., Tsoi P.S., Moosa M.M., Paulucci-Holthauzen A., Liao S.J., Ferreon J.C., Ferreon A.C.M. A Chemical Chaperone Decouples TDP-43 Disordered Domain Phase Separation from Fibrillation. Biochemistry. 2018;57:6822&#x2013;6826. doi: 10.1021/acs.biochem.8b01051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b01051</ArticleId><ArticleId IdType="pmc">PMC6555487</ArticleId><ArticleId IdType="pubmed">30520303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Gumina V., Lenzi P., Bossolasco P., Fulceri F., Volpe C., Bardelli D., Pregnolato F., Maraschi A., Fornai F., et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudevan A., Koushika S.P. Molecular mechanisms governing axonal transport: A C. elegans perspective. J. Neurogenet. 2020;34:282&#x2013;297. doi: 10.1080/01677063.2020.1823385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2020.1823385</ArticleId><ArticleId IdType="pubmed">33030066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J.N., Tosolini A.P., Gordon D., Devoy A., Fratta P., Fisher E.M.C., Talbot K., Schiavo G. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes. Cell Rep. 2020;30:3655&#x2013;3662.e3652. doi: 10.1016/j.celrep.2020.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.078</ArticleId><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S., Twelvetrees A.E., Moughamian A.J., Holzbaur E.L. Axonal transport: Cargo-specific mechanisms of motility and regulation. Neuron. 2014;84:292&#x2013;309. doi: 10.1016/j.neuron.2014.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.019</ArticleId><ArticleId IdType="pmc">PMC4269290</ArticleId><ArticleId IdType="pubmed">25374356</ArticleId></ArticleIdList></Reference><Reference><Citation>Collard J.F., C&#xf4;t&#xe9; F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375:61&#x2013;64. doi: 10.1038/375061a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375061a0</ArticleId><ArticleId IdType="pubmed">7536898</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999;2:50&#x2013;56. doi: 10.1038/4553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4553</ArticleId><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Zhou J., Li Y., Wu K., Chen Z., Luo Z., Zhang X., Liang Y., Esteban M.A., Zhou Y., et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 2021 doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G., Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion. 2005;5:77&#x2013;87. doi: 10.1016/j.mito.2005.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2005.01.002</ArticleId><ArticleId IdType="pubmed">16050975</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S.A., Itaman S., Khalid-Janney C.M., Sherard J.A., Dowell J.A., Cairns N.J., Gitcho M.A. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci. Lett. 2018;678:8&#x2013;15. doi: 10.1016/j.neulet.2018.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.053</ArticleId><ArticleId IdType="pmc">PMC5975202</ArticleId><ArticleId IdType="pubmed">29715546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Xie E.F., Kocak N., Ozdinler P.H. Mitoautophagy: A Unique Self-Destructive Path Mitochondria of Upper Motor Neurons With TDP-43 Pathology Take, Very Early in ALS. Front. Cell Neurosci. 2019;13:489. doi: 10.3389/fncel.2019.00489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00489</ArticleId><ArticleId IdType="pmc">PMC6854036</ArticleId><ArticleId IdType="pubmed">31787882</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumikawa K., Nobe Y., Yoshikawa H., Ishikawa H., Miura Y., Nakayama H., Nonaka T., Hasegawa M., Egawa N., Inoue H., et al. TDP-43 stabilises the processing intermediates of mitochondrial transcripts. Sci. Rep. 2017;7:7709. doi: 10.1038/s41598-017-06953-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06953-y</ArticleId><ArticleId IdType="pmc">PMC5550480</ArticleId><ArticleId IdType="pubmed">28794432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M., Wang T., Sun L., Wang L., Lee A.Y., et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Duan W., Guo Y., Li Z., Han H., Zhang S., Yuan P., Li C. A new cellular model of pathological TDP-43: The neurotoxicity of stably expressed CTF25 of TDP-43 depends on the proteasome. Neuroscience. 2014;281:88&#x2013;98. doi: 10.1016/j.neuroscience.2014.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.09.043</ArticleId><ArticleId IdType="pubmed">25270903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K., Li Y., Duan W., Guo Y., Jiang H., Li W., Li C. Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line. Neurosci. Lett. 2012;530:144&#x2013;149. doi: 10.1016/j.neulet.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.10.003</ArticleId><ArticleId IdType="pubmed">23063673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Arakawa H., Wang L., Okolo O., Siedlak S.L., Jiang Y., Gao J., Xie F., Petersen R.B., Wang X. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization. Mol. Ther. 2017;25:127&#x2013;139. doi: 10.1016/j.ymthe.2016.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2016.10.013</ArticleId><ArticleId IdType="pmc">PMC5363201</ArticleId><ArticleId IdType="pubmed">28129109</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.F., Vizcay-Barrena G., Lin W.L., Xu Y.F., Lewis J., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Duan Y., Qin C., Li J.C., Duan G., Deng X., Ni J., Cao X., Xiang K., Tian K., et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9:953. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Farrimond L., Candalija A., Scaber J., Ababneh N.A., Sathyaprakash C., Vowles J., Cowley S.A., Talbot K. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Stem Cell Rep. 2020;14:892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;gan C., Vila M., Rosoklija G., Hays A.P., Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 2001;21:6569&#x2013;6576. doi: 10.1523/JNEUROSCI.21-17-06569.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-17-06569.2001</ArticleId><ArticleId IdType="pmc">PMC6763092</ArticleId><ArticleId IdType="pubmed">11517246</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S., Long J.C., C&#xe1;ceres J.F. hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell Biol. 2006;26:5744&#x2013;5758. doi: 10.1128/MCB.00224-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00224-06</ArticleId><ArticleId IdType="pmc">PMC1592774</ArticleId><ArticleId IdType="pubmed">16847328</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Mitra J., Wang H., Rangaswamy S., Hegde P.M., Basu P., Rao K.S., Hegde M.L. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum. Mol. Genet. 2019;28:2459&#x2013;2476. doi: 10.1093/hmg/ddz062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Gordon D., Thompson A.G., Finelli M.J., Dafinca R., Candalija A., Charles P.D., M&#xe4;ger I., Wood M.J., Fischer R., et al. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol. Dis. 2020;144:105050. doi: 10.1016/j.nbd.2020.105050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105050</ArticleId><ArticleId IdType="pubmed">32800996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Protein Quality Control by Molecular Chaperones in Neurodegeneration. Front. Neurosci. 2017;11:185. doi: 10.3389/fnins.2017.00185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00185</ArticleId><ArticleId IdType="pmc">PMC5382173</ArticleId><ArticleId IdType="pubmed">28428740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostova Z., Wolf D.H. For whom the bell tolls: Protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J. 2003;22:2309&#x2013;2317. doi: 10.1093/emboj/cdg227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdg227</ArticleId><ArticleId IdType="pmc">PMC155985</ArticleId><ArticleId IdType="pubmed">12743025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotzl J.K., Lang C.M., Haass C., Capell A. Impaired protein degradation in FTLD and related disorders. Ageing Res. Rev. 2016;32:122&#x2013;139. doi: 10.1016/j.arr.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.04.008</ArticleId><ArticleId IdType="pubmed">27166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautenschlaeger J., Prell T., Grosskreutz J. Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:166&#x2013;177. doi: 10.3109/17482968.2011.641569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.641569</ArticleId><ArticleId IdType="pubmed">22292840</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Ryskalin L., Busceti C.L., Fornai F. Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium. Front. Cell Neurosci. 2019;13:450. doi: 10.3389/fncel.2019.00450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00450</ArticleId><ArticleId IdType="pmc">PMC6797817</ArticleId><ArticleId IdType="pubmed">31680867</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter P., Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science. 2011;334:1081&#x2013;1086. doi: 10.1126/science.1209038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1209038</ArticleId><ArticleId IdType="pubmed">22116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A., Patten S.A., Aggad D., Julien C., Maios C., Kabashi E., Drapeau P., Parker J.A. Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol. Dis. 2013;55:64&#x2013;75. doi: 10.1016/j.nbd.2013.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.015</ArticleId><ArticleId IdType="pubmed">23567652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutihac R., Alegre-Abarrategui J., Gordon D., Farrimond L., Yamasaki-Mann M., Talbot K., Wade-Martins R. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca2+ signaling in motor neurons. Neurobiol. Dis. 2015;75:64&#x2013;77. doi: 10.1016/j.nbd.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.010</ArticleId><ArticleId IdType="pubmed">25526708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhou S., Ding X., Ma M., Zhang J., Zhou Y., Wu E., Teng J. Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation. Int. J. Biol. Sci. 2015;11:1140&#x2013;1149. doi: 10.7150/ijbs.12657.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.12657</ArticleId><ArticleId IdType="pmc">PMC4551750</ArticleId><ArticleId IdType="pubmed">26327808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong B., Radulovic M., Figueiredo-Pereira M.E., Cardozo C. The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer&#x2019;s Disease and Spinal Cord Injury. Front. Mol. Neurosci. 2016;9:4. doi: 10.3389/fnmol.2016.00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00004</ArticleId><ArticleId IdType="pmc">PMC4727241</ArticleId><ArticleId IdType="pubmed">26858599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantuma N.P., Bott L.C. The ubiquitin-proteasome system in neurodegenerative diseases: Precipitating factor, yet part of the solution. Front. Mol. Neurosci. 2014;7:70. doi: 10.3389/fnmol.2014.00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2014.00070</ArticleId><ArticleId IdType="pmc">PMC4117186</ArticleId><ArticleId IdType="pubmed">25132814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Jeon Y.M., Cha S.J., Kim S., Kwon Y., Jo M., Jang Y.N., Lee S., Kim J., Kim S.R., et al. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies. Autophagy. 2020;16:1396&#x2013;1412. doi: 10.1080/15548627.2019.1686729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1686729</ArticleId><ArticleId IdType="pmc">PMC7469499</ArticleId><ArticleId IdType="pubmed">31690171</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., De Septenville A., Millecamps S., Camuzat A., Caroppo P., Couratier P., Blanc F., Lacomblez L., Sellal F., Fleury M.C., et al. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol. Aging. 2015;36:3116.e5&#x2013;3116.e8. doi: 10.1016/j.neurobiolaging.2015.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.009</ArticleId><ArticleId IdType="pubmed">26476236</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster A.D., Downing P., Figredo E., Polain N., Stott A., Layfield R., Rea S.L. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation. Mol. Cell Neurosci. 2020 doi: 10.1016/j.mcn.2020.103539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103539</ArticleId><ArticleId IdType="pubmed">32835772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R., Fani G., Capitini C., Rusmini P., Poletti A., Cecchi C., Chiti F. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy. FASEB J. 2017;31:5609&#x2013;5624. doi: 10.1096/fj.201700292RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700292RR</ArticleId><ArticleId IdType="pubmed">28842427</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Sato T., Bamba H., Hisa Y., Tooyama I. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J. Neurosci. Res. 2010;88:784&#x2013;797. doi: 10.1002/jnr.22243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22243</ArticleId><ArticleId IdType="pubmed">19798749</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Fan H., Ying Z., Li B., Wang H., Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci. Lett. 2010;469:112&#x2013;116. doi: 10.1016/j.neulet.2009.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.11.055</ArticleId><ArticleId IdType="pubmed">19944744</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki W., Minegishi S., Motoki K., Kume H., Hohjoh H., Araki Y.M., Tamaoka A. Disease-associated mutations of TDP-43 promote turnover of the protein through the proteasomal pathway. Mol. Neurobiol. 2014;50:1049&#x2013;1058. doi: 10.1007/s12035-014-8644-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8644-6</ArticleId><ArticleId IdType="pubmed">24477737</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eersel J., Ke Y.D., Gladbach A., Bi M., Gotz J., Kril J.J., Ittner L.M. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLoS ONE. 2011;6:e22850. doi: 10.1371/journal.pone.0022850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022850</ArticleId><ArticleId IdType="pmc">PMC3146516</ArticleId><ArticleId IdType="pubmed">21829535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro Y., Urushitani M., Inoue H., Koike M., Uchiyama Y., Komatsu M., Tanaka K., Yamazaki M., Abe M., Misawa H., et al. Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J. Biol. Chem. 2012;287:42984&#x2013;42994. doi: 10.1074/jbc.M112.417600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.417600</ArticleId><ArticleId IdType="pmc">PMC3522293</ArticleId><ArticleId IdType="pubmed">23095749</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Shaw D.M., Guarino F., Messina A., Walker A.W., Oddo S. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43. Hum. Mol. Genet. 2015;24:4625&#x2013;4635. doi: 10.1093/hmg/ddv193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv193</ArticleId><ArticleId IdType="pubmed">26002100</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., Nixon R.A. Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer&#x2019;s disease. J. Neurosci. 2008;28:6926&#x2013;6937. doi: 10.1523/JNEUROSCI.0800-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0800-08.2008</ArticleId><ArticleId IdType="pmc">PMC2676733</ArticleId><ArticleId IdType="pubmed">18596167</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Rusmini P., Meroni M., Ferrari V., Vezzoli G., Tedesco B., Piccolella M., Messi E., Galbiati M., et al. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells. Sci. Rep. 2018;8:12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.F., Lee Y.C., Lee K.H., Lin H.C., Chen C.L., Shen C.J., Huang C.C. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J. Biomed. Sci. 2016;23:72. doi: 10.1186/s12929-016-0290-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-016-0290-z</ArticleId><ArticleId IdType="pmc">PMC5073438</ArticleId><ArticleId IdType="pubmed">27769241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wang H., Ying Z., Gao Q. Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy. Biochem. Biophys. Res. Commun. 2020;526:231&#x2013;238. doi: 10.1016/j.bbrc.2020.03.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.051</ArticleId><ArticleId IdType="pubmed">32204915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu F.T., Wang Y.X., Guan R.Y., Chen C., Li D.K., Bu L.L., Song J., Yang Y.J., Dong Y., et al. Autophagic Modulation by Trehalose Reduces Accumulation of TDP-43 in a Cell Model of Amyotrophic Lateral Sclerosis via TFEB Activation. Neurotox Res. 2018;34:109&#x2013;120. doi: 10.1007/s12640-018-9865-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-018-9865-7</ArticleId><ArticleId IdType="pubmed">29383655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;chter N., Storch A., Hermann A. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms. Amyotroph. Lateral Scler. Front. Degener. 2015;16:431&#x2013;441. doi: 10.3109/21678421.2015.1055275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1055275</ArticleId><ArticleId IdType="pubmed">26174443</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Sun Y.E. Glial cells more than support cells? Int. J. Biochem. Cell Biol. 2007;39:661&#x2013;665. doi: 10.1016/j.biocel.2006.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2006.10.022</ArticleId><ArticleId IdType="pubmed">17141551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Park J., Choi Y.K. The Role of Astrocytes in the Central Nervous System Focused on BK Channel and Heme Oxygenase Metabolites: A Review. Antioxidants. 2019;8:121. doi: 10.3390/antiox8050121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8050121</ArticleId><ArticleId IdType="pmc">PMC6562853</ArticleId><ArticleId IdType="pubmed">31060341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V. Astrogliosis. Cold Spring Harb. Perspect. Biol. 2014;7:a020420. doi: 10.1101/cshperspect.a020420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020420</ArticleId><ArticleId IdType="pmc">PMC4315924</ArticleId><ArticleId IdType="pubmed">25380660</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallings N.R., Puttaparthi K., Luther C.M., Burns D.K., Elliott J.L. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol. Dis. 2010;40:404&#x2013;414. doi: 10.1016/j.nbd.2010.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.06.017</ArticleId><ArticleId IdType="pubmed">20621187</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Zhang Y.J., Lin W.L., Cao X., Stetler C., Dickson D.W., Lewis J., Petrucelli L. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol. Neurodegener. 2011;6:73. doi: 10.1186/1750-1326-6-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-73</ArticleId><ArticleId IdType="pmc">PMC3216869</ArticleId><ArticleId IdType="pubmed">22029574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K.J., Yang C.H., Fang Y.H., Cho K.H., Chien W.L., Wang W.T., Wu T.W., Lin C.P., Fu W.M., Shen C.K. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 2010;207:1661&#x2013;1673. doi: 10.1084/jem.20092164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20092164</ArticleId><ArticleId IdType="pmc">PMC2916125</ArticleId><ArticleId IdType="pubmed">20660618</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Chiang P.M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. USA. 2010;107:16325&#x2013;16330. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y.D., van Hummel A., Stevens C.H., Gladbach A., Ippati S., Bi M., Lee W.S., Kr&#xfc;ger S., van der Hoven J., Volkerling A., et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol. 2015;130:661&#x2013;678. doi: 10.1007/s00401-015-1486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1486-0</ArticleId><ArticleId IdType="pubmed">26437864</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton S.K., Lau C.L., Chiam M.D.F., Tomas D., Muyderman H., Beart P.M., Turner B.J. Mutant TDP-43 Expression Triggers TDP-43 Pathology and Cell Autonomous Effects on Primary Astrocytes: Implications for Non-cell Autonomous Pathology in ALS. Neurochem. Res. 2020;45:1451&#x2013;1459. doi: 10.1007/s11064-020-03048-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03048-5</ArticleId><ArticleId IdType="pubmed">32410044</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., Xia X.G. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Plotkin S.S., Yerbury J.J., Cashman N.R. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Kuo P.H., Chu L.Y., Golzarroshan B., Jain M., Yuan H.S. RNA recognition motifs of disease-linked RNA-binding proteins contribute to amyloid formation. Sci. Rep. 2019;9:6171. doi: 10.1038/s41598-019-42367-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42367-8</ArticleId><ArticleId IdType="pmc">PMC6467989</ArticleId><ArticleId IdType="pubmed">30992467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q., Boyer D.R., Sawaya M.R., Ge P., Eisenberg D.S. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 2019;26:619&#x2013;627. doi: 10.1038/s41594-019-0248-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0248-4</ArticleId><ArticleId IdType="pmc">PMC7047951</ArticleId><ArticleId IdType="pubmed">31235914</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther E.L., Cao Q., Trinh H., Lu J., Sawaya M.R., Cascio D., Boyer D.R., Rodriguez J.A., Hughes M.P., Eisenberg D.S. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 2018;25:463&#x2013;471. doi: 10.1038/s41594-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC5990464</ArticleId><ArticleId IdType="pubmed">29786080</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Watanabe S., Yamanaka K., Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 2011;286:18664&#x2013;18672. doi: 10.1074/jbc.M111.231209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.231209</ArticleId><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Masuda-Suzukake M., Arai T., Hasegawa Y., Akatsu H., Obi T., Yoshida M., Murayama S., Mann D.M., Akiyama H., et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S., Xu Y., Restrepo C.R., Kwong L.K., Zhang B., Brown H.J., Lee E.B., Trojanowski J.Q., Lee V.M. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 2018;9:4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Newcombe J., Troakes C., Simone R., Chen Y.R., Patani R., Sidle K. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 2016;96:236&#x2013;247. doi: 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R., Whiten D.R., Farrawell N.E., McAlary L., Hanspal M.A., Kumita J.R., Wilson M.R., Yerbury J.J. Flow cytometric measurement of the cellular propagation of TDP-43 aggregation. Prion. 2017;11:195&#x2013;204. doi: 10.1080/19336896.2017.1314426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1314426</ArticleId><ArticleId IdType="pmc">PMC5480386</ArticleId><ArticleId IdType="pubmed">28486039</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler M.S., Strobel B., Freischmidt A., Helferich A.M., Kappel J., Brewer B.M., Li D., Thal D.R., Walther P., Ludolph A.C., et al. TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.J., Chern Y. AMPK-mediated regulation of neuronal metabolism and function in brain diseases. J. Neurogenet. 2015;29:50&#x2013;58. doi: 10.3109/01677063.2015.1067203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1067203</ArticleId><ArticleId IdType="pubmed">26119401</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera N.D., Sheean R.K., Scott J.W., Kemp B.E., Horne M.K., Turner B.J. Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. PLoS ONE. 2014;9:e95549. doi: 10.1371/journal.pone.0090449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090449</ArticleId><ArticleId IdType="pmc">PMC3989332</ArticleId><ArticleId IdType="pubmed">24740287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>